Barclays analyst issues OVERWEIGHT recommendation for ARRY on January 14, 2025 11:36PM ET. The previous analyst recommendation was Overweight.ARRY was trading at $6.93 at issue of the analyst recommendation.The overall...
Piper Sandler analyst issues OVERWEIGHT recommendation for VLO on January 10, 2025 03:36PM ET. The previous analyst recommendation was Neutral.VLO was trading at $127.15 at issue of the analyst recommendation.The...
Barclays analyst issues OVERWEIGHT recommendation for ET on January 13, 2025 11:17AM ET. The previous analyst recommendation was Overweight.ET was trading at $19.49 at issue of the analyst recommendation.The overall...
Barclays analyst issues OVERWEIGHT recommendation for TRGP on January 13, 2025 11:23AM ET. The previous analyst recommendation was Overweight.TRGP was trading at $187.82 at issue of the analyst recommendation.The overall...
UBS analyst issues BUY recommendation for SHEL on January 8, 2025 05:07PM ET. The previous analyst recommendation was Neutral.SHEL was trading at $64.72 at issue of the analyst recommendation.The overall...
UBS analyst issues NEUTRAL recommendation for E on January 8, 2025 05:00PM ET. E was trading at $27.99 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current analyst...
UBS analyst issues BUY recommendation for CEG on January 8, 2025 10:46PM ET. The previous analyst recommendation was Buy.CEG was trading at $243.84 at issue of the analyst recommendation.The overall...
Wolfe Research analyst issues OUTPERFORM recommendation for OXY on January 3, 2025 10:55AM ET. The previous analyst recommendation was Outperform.OXY was trading at $50.066 at issue of the analyst recommendation.The...
BMO Capital analyst issues OUTPERFORM recommendation for PBA on December 13, 2024 03:38PM ET. The previous analyst recommendation was Outperform.PBA was trading at $38.97 at issue of the analyst recommendation.The...
Raymond James analyst issues OUTPERFORM recommendation for CVE on December 13, 2024 04:04PM ET. The previous analyst recommendation was Outperform.CVE was trading at $15.12 at issue of the analyst recommendation.The...
